Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

COVID outcomes predictor suffers only slight sophomore slump

The model’s consistent overall accuracy demonstrates the reusability of existing COVID algorithms with recalibrations rather than fallbacks to square one, AI developers suggest.

Thumbnail

Medicare improves racial healthcare inequities

Medicare is associated with reductions in racial and ethnic disparities in insurance coverage, access to care and self-reported health across the U.S., according to a new study published in JAMA.

 

Bias-resistant AI advances personalized medicine in surgery

Researchers in Denmark and the U.S. have used deep neural networks to develop complementing models for predicting complications likely to arise in patients who’ve had surgeries of all kinds. 

AI separates EHR wheat from weeds so clinicians can get on with patient care

When assisted by an AI tool designed to organize and display digitized patient referral records, gastroenterologists cut their time to answer relevant clinical questions by 2.3 minutes.

Thumbnail

Lonely older adults take more high-risk medications

Being lonely has some correlation to higher use in riskier medications among older adults, according to a new study.

 

Thumbnail

Scholarly futurists project healthcare AI’s trajectory across 3 time windows

Beginning around 2031, autonomous virtual assistants will deliver precision preventive medicine while networked provider orgs offer closely connected care via single, shared digital infrastructures.

AI biopsy dilemma: Wolf or husky, equity or bias?

Early on in the development of digital image recognition, the technology showed a penchant for taking logical but potentially problematic shortcuts: It would look to image artifacts and incidental “asides” such as background features to distinguish between two visually similar subjects.

AI casts wide net to predict functional decline in the elderly

Psychology researchers have used machine learning to wring useful two-year dementia trajectory predictions from more than 500 potentially contributing risk factors.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup